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Abstract: Medicines management is a high-risk and error prone process in healthcare settings,
where nurses play an important role to preserve patient safety. In order to create a safe healthcare
environment, nurses should recognize challenges that they face in this process, understand factors
leading to medication errors, identify errors and systematically address them to prevent their future
occurrence. “Pro re nata” (PRN, as needed) medicine administration is a relatively neglected area of
medicines management in nursing practice, yet has a high potential for medication errors. Currently,
the international literature indicates a lack of knowledge of both the competencies required for PRN
medicines management and the optimum educational strategies to prepare students for PRN medicines
management. To address this deficiency in the literature, the authors have presented a discussion on
nurses’ roles in medication safety and the significance and purpose of PRN medications, and suggest
a model for preparing nursing students in safe PRN medicines management. The discussion takes
into account patient participation and nurse competencies required to safeguard PRN medication
practice, providing a background for further research on how to improve the safety of PRN medicines
management in clinical practice.
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1. Burden of Medication Errors
Adverse effects of medical treatment are a serious public health problem, and one of the leading
causes of death worldwide [1–3]. Preventable harm affects 6% of patients (95% confidence intervals:
5–7%), and some 25% of incidents relate to medicines [1]. Medication errors affect all areas of healthcare,
including hospitals, outpatient and general practice facilities, nursing homes, pharmacies and patient
homes [2,4]. Within this paper, we use Aronson’s definition of a medication error, i.e.,
is an avoidable adverse effect of healthcare, whether or not it is obvious or harmful to the
patient something incorrectly done through ignorance or inadvertence; a mistake, e.g., in
calculation, judgement, speech, writing, action, or a failure to complete a planned action as
intended, or the use of an incorrect plan of action to achieve a given aim [5] (p. 6013).
Not all medication errors are harmful, but they are often preventable [6,7]. An analysis of
mortality rates by John Hopkins University over an eight-year period estimates that more than 250,000
deaths per year in the United States are attributable to healthcare errors [4], of which medication
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errors are the most common. Errors can occur multiple times during medicines management: this
includes errors in prescribing, supplying, dispensing, preparing, administering or monitoring patients
for medications’ side effects and adverse drug reactions (ADRs) [8]. Nevertheless, one third of all
medication errors occur during medication administration [4]. Data from the European region show
that the median percentages of hospital admissions due to ADRs and patients experiencing ADRs
during hospitalization are 3.5% and 10.1%, respectively [9], and more serious ADRs often remain
under-reported [10,11]. In healthcare systems, medication errors cause avoidable costs of between
approximately €4.5 and 21.8 billion annually [12], and are important reasons for hospital admissions
and mortality [13]. As such, healthcare organizations have the responsibility to establish a safety culture
that focuses on improving the system and treats medication errors as challenges to be recognized and
overcome [2]. Accordingly, a crucial step forward for the culture of safety in medicines management lies
in the systematic identification and reporting of near-misses and errors during medication prescription,
administration and follow up [14–16].
2. Nurses’ Roles in Medicines Management
As members of the health care team, nurses play a key role in medication safety. It is their
job to prepare medication; calculate correct doses; and administer medication and monitor its
effects, interactions or side effects, requiring up-to-date knowledge and skills relating to medicines
management [17,18]. Nurses are directly involved in the care of patients and monitor the safety
of medication before, during and after administration. It has been estimated that the medication
administration procedure consumes up to 40% of the nurse’s time in a work shift [19]. They provide
information and training to patients and give instructions on the safe use of medication during
discharge [20]. Moreover, nurses, as mentors on clinical placements, play an essential role in training
nursing students in safe medicines management [21].
On average, a nurse administers 10 doses of medication daily for each hospital patient [22].
Data from European Union Member States consistently show that medical errors and adverse events
related to healthcare occur in 8% to 12% of hospital stays [23]. Increased potential for medication errors
is evident in intensive care units (ICUs), where these are the most common type of error at 78% of cases.
Critically ill patients admitted to intensive care units accumulate an average of 1.7 medical errors per
day [24,25]. A study in the UK showed that 5796 medication errors happened over four data collection
periods during 2014 and 2015 in various hospital wards [26]. Medication errors also occur frequently
in long-term care, often due to lack of knowledge and competence, under-reporting of medication
errors, confusion between trade-name products vs. generics, and work routines [27,28]. According to
the results of a systematic review, 16–27% of nursing homes’ residents experienced medication errors.
Although 75% of them were prescribed at least one potentially inappropriate medication, this remained
underreported [29].
Nurses should gain required competencies in terms of knowledge and skills within regulatory,
professional, legal and ethical frameworks regarding the prescription, storage, administration and
safe disposal of medications. After receiving approprierte theoretical education and practical training,
many nurses are authorized to prescribe medications from the national formulary within their scope of
practice [30]. Therefore, they need to recognize the challenges they face in medicines management
from prescription to administration, and follow-up of related side effects, and play their key role in the
prevention of medication errors. They must be able to identify their own errors as well as those made
by other healthcare providers, including pharmacists and physicians, and take appropriate preventive
actions when administering medicines [14]. Additionally, they have to identify, report and manage
errors committed by nursing students during their mentorship period [21,31]. It is therefore essential
that factors contributing to errors are identified and systematically addressed in order to effectively
improve patient safety. Such a perspective is in line with the World Health Organization’s (WHO) 3rd
Global Patient Safety Challenge on Medication Safety. This challenge calls for creative initiatives to
reduce severe, avoidable medication-associated harm in all countries by 50% over the next 5 years
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by all healthcare staff, including nurses, with the aim of reducing the length of hospital stays and the
overall cost of healthcare, and improving patients’ well-being and satisfaction with care [32].
3. PRN Medication
“Pro re nata” (PRN) is defined as the prescription of medications whose administration should
be based on patients’ immediate needs rather than at predetermined administration times [33,34].
PRN prescription and administration is commonly used for psychotropic and psycholeptic
medications, including antipsychotics (neuroleptics), anxiolytics, sedatives, and hypnotics, analgesics,
gastro-intestinal preparations and other medicines used for relieving physical and psychological
symptoms [34–39].
PRN medicines management is a crucial instrument in guiding the involvement of nurses
working in a range of healthcare units, by which patients’ physical and mental sufferings are relieved
based on nurses’ decision-making [28]. As front line staff in healthcare settings, nurses are located
in the best position to systematically monitor patients’ needs, use their knowledge and skills and
apply their authority regarding medication practice for making appropriate decisions on medicines
management [40,41].
PRN prescription and administration aim to provide medicines as a complement to regularly
scheduled medications, characterized by empowering both nurses and patients and providing flexibility
for relieving physical and mental suffering and pain [42]. They are associated with an increase in
the feeling of professional autonomy and a sense of self-worth and accomplishment for nurses in
clinical practice [43]. Nonetheless, decision-making for PRN medicines by nurses is a complex task
and is influenced by their pharmacotherapeutic competencies and skills, together with organizational
routines and patient and family involvement [38]. The safety of PRN medicines management depends
on close collaboration and partnerships between patients, nurses, physicians and pharmacists [44].
The high rate of PRN prescription and administration highlights the need for developing
appropriate strategies for ensuring safe and appropriate PRN medicines management [37], especially
given the current lack of relevant evidence-based clinical guidelines and instructions for practice at
both national and international level [45]. PRN medicines form a significant proportion of medication
errors, at between 9–40% in intensive care units; furthermore, PRN medications are especially likely
to contribute to medical errors [34,46–48]. This is significant, given that over 90% of patients with
psychiatric disorders receive at least one PRN medication [33]; 20–86% of nursing home residents
receive some PRN drug administration [36,49]; and in outpatient clinics, the prevalence rate is about
77% [50]. However, more than one-third of patients are not monitored regarding their continuous
needs for PRN medications after starting their prescriptions [35].
PRN medicines management has many benefits, but its inappropriate use can lead to polypharmacy,
overdosing and over- or under-use, and administration without the patient’s consent or full disclosure
of relevant information about medications [48]. Higher numbers of PRN prescriptions are associated
with longer stays in nursing homes (median of 2.1 years), and polypharmacy (defined as ≥5 long-term
medicines) [51].
Currently, many nursing students are not educated on PRN medicines management during
degree courses, but studies have shown the effectiveness of nurses’ education on how to safely
handle PRN medications’ prescription and administration [28]. Therefore, controversies surrounding
PRN medicines management frequently consist of inappropriate assessment of patients’ outcomes,
medications’ adverse side effects, and unclear documentation [52]. Crucially, there is an ongoing
need for alignment of healthcare practice with clinical guidelines and improvements to the culture
and practice surrounding PRN medications [53], together with standardization of PRN medicines
management from prescription to administration and assessment of its side effects and any ADRs [54].
Clear educational strategies on PRN medication are also required, addressing how these are prescribed,
administered and assessed in terms of their effects on the patients’ health conditions and care
outcomes [48].
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Nurse education is central to addressing these challenges: studies indicate the effectiveness of
educational sessions for nursing staff on PRN medications in reducing the overall use of common
medications including laxatives and hypnotics by 34–70% [55]. Empowering nurses through education
clarifies the flow and coordination of activities, from medication prescription to follow-up and
monitoring of side effects, by a multidisciplinary healthcare team [28,41]. It upgrades nurses’ positions
in the process of patient care and medicines management, improves nurses’ involvement in medication
safety and effectively motivates them to mobilize their theoretical knowledge and clinical judgment to
achieve positive care outcomes. This in turn increases their job satisfaction and the feeling of autonomy,
and consequently improves patient care outcomes [56,57]. However, there is a paucity of knowledge
regarding appropriate education and training for nurses in PRN medicines management. We address
this crucial oversight in the current literature by developing a model for these processes below.
4. A Model for Education in PRN Medicines Management
Central to the identity and aims of PRN is a mutual, caring relationship between the patient and
the nurse [34]: both of these actors have a mutual responsibility to ensure the safety of PRN [34,58].
Therefore, our suggested model (Figure 1) for the education of nursing students in ensuring safe PRN
practice focuses on “patient participation” and “nurse competencies” as follows.
Figure 1. Model of the nursing education of pro re nata (PRN) medicines management.
4.1. Patient Participation
Nursing students should be educated regarding the significance of the patient’s role and
participation in their own medicines management. They should be taught about educating patients
and empowering them to monitor their own medication process in order to provide inputs about their
needs as the basis for making decisions on PRN prescription and administration by nurses.
Patient education, as one side of the joint empowerment approach for both the healthcare provider
and healthcare receiver, guarantees adherence to the principles of safe medication therapy [59]. This is
characterized by a mutual understanding between the nurse and patient of the therapeutic reasons
behind PRN medications’ prescription and administration to meet the real patient’s healthcare needs
for medications [34]. Ideally, patients should be able to be trusted to perform a regular and unilateral
evaluation of their medication process without healthcare providers’ participation [60]. If a patient is
unable to take responsibility for their medication, relatives or informal caregivers can be educated and
asked to manage the patient’s medication [61–63]. Informal and family caregivers can participate in
the physical handling of PRN medication in terms of obtaining medications, preparing pillboxes or
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assisting with medication administration, organizing/tracking medications, collecting information and
making treatment decisions [61], and educational activities as patient representatives [64]. Nevertheless,
all reasonable measures should be used to encourage patients to take an active role [65,66].
Nursing students require training in communication skills, to meet expectations for engagement
in PRN medication communication in line with a patient-centered approach to care [66] as has been
depicted in Figure 2. They need to work from the standpoint that patients have the ability to learn
about the medication process and can give meaningful reports on errors, near misses and discrepancies
leading to patient harm [67,68]. It is crucial that nurses are able to give a voice to patients and invite
them to become part of the decision-making process, through sharing information based on their
literacy level and uncertainties [69]. The occasions of medication administration can be used to engage
patients in medicines management, with an emphasis on informing patients regarding medications
with implications for their own safety [70]. Patient requests to receive PRN medications should be
considered a prompt for nurses to communicate with patients and inform them about the probable
risks and benefits of medications along with their own role in the regular assessment and reporting of
medications’ side effects [42]. The use of medical jargon and taking important medication decisions
away from the patient’s bedside should be avoided [71]: this approach to care gives patients the feeling
of ownership and control over medication administration and, by extension, their own physical and
mental wellbeing [72,73].
Figure 2. Patient participation in PRN medicines management.
4.2. Nurse Competencies
Competencies, as the core abilities by which nurses’ safely fulfil their roles and responsibilities [74],
should be practically described for PRN medicines management and should form a guide for education.
The European Federation of Nurses (EFN) Associations Guidelines describe the list of competencies for
nurses responsible for general patient care in Article 31 of the Directive 2013/55/EU [75], and suggests
its consideration in European nursing curricula. In Committee Competences A, D, and E of the
professional qualifications directives (Directive 2013/55/EU and 2005/36/EC), the EFN Competence
6, “nursing care education and training”, indicates the recommended content of safe management
of medicines and prescribing [76] (p. 24) as well as a set of student outcomes related to medicines
management, as follows:
• Pharmacology knowledge;
• Medicine typologies;
• Pharmacokinetics;
• Administration method/dosage, interactions, circumstances that modify medicines management,
contraindications, ADRs;
• Safe medicine management, and medication administration skills;
• Taking into account patient characteristics such as age, pathology and health condition in medicines
management [76] (pp. 26–27);
• Taking a standardized medication history for medication reconciliation and detecting probable
discrepancies [77].
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With respect to nurse prescribing, as is in line with PRN medicines management, the EFN suggests
the inclusion of learning outcomes that focus on the management of healthcare products linked to
nursing care, and integrating the prescribing process into the nursing care process [76] (p. 27).
As such, for the purposes of this discussion we have divided nurse competencies for PRN medicines
management into the categories of “knowledge and skills”, “independence and interdependence in
decision making”, and “monitoring and follow up”, all of which are described below and summarized
in Table 1.
Table 1. Summary of nurse competencies for safe PRN medicines management.
Competency Category Principles Educational Strategy
Knowledge and skills
Selection of
appropriate medications;
Team work and interprofessional
communication;
Guidelines and policies;
Rights of medicines management;
Condition, dose and effectiveness
of medications;
Medication-taking history;
Medication calculation and
administration
Provision of opportunities to
practice at bedside;
Computer-based methods;
High-fidelity simulation;
Problem-based learning;
Reflection and discussion;
Supervision and role model;
Case study learning
Independence and
interdependence in
decision making
Making independent
clinical decisions;
Feeling of responsibility;
Linking between interventions
and patient’s well-being;
Double checking;
Nurse-patient collaboration;
Involvement of healthcare staff;
Use of interprofessional
communication tools;
Valuing and respecting skills
and responsibilities;
Use of information technology
Self-reflection and criticism;
Provision of controlled
decision-making situations;
Being mentored by clinical nurses;
Provision of safe environment for
the medication process;
Interprofessional education;
Monitoring and follow up
Assessing care outcomes before,
during and after medication;
Monitoring abuse;
Use of monitoring tools
and profiles;
Monitoring patients for the signs
and symptoms of known adverse
side effects and reporting anything
that may be related to the PRN
medicine to pharmacists or
prescribers.
ADR: adverse drug reaction.
4.2.1. Knowledge and Skills
Measures to prevent medication errors and improve relevant aspects of patient safety are central
elements in the competency-based education of medicines management [78]. These measures are
characterized by integrated and comprehensive education throughout the undergraduate program,
giving consideration to students’ learning styles and encouraging the students to self-regulate and
improve their own learning [79,80]. Experience gained by nursing students during their basic education
has long-lasting influence on how they perceive their role in medicines management, underpinning
the need for well-established educational strategies [81].
Moreover, nursing students should be equipped with clinical knowledge and skills on how to
use their theoretical knowledge about medication at the patient’s bedside [82], and, for instance,
how to select appropriate medications for PRN [83]. As PRN medicines management depends
on both teamwork and system-related factors, nursing students should also have knowledge of
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inter-professional communication, the complexity of care processes and relevant organizational
structures such as guidelines and policies [81,84].
The essential concepts for PRN medication training are the 10 “rights” of medicines management:
right patient, right reason, right drug, right route, right time, right dose, right form, right action,
right documentation and right response [85]. In addition, in all cases of PRN medication, written
guidelines and procedures for administering PRN medication should be verified in advance, including
the following details:
• Circumstances affecting the use of PRN medications, including clinical and laboratory parameters;
• Doses, including the exact time and the maximum dose in a 24-hour period;
• Evaluation of the effectiveness of PRN medications after a determined time period [18];
• Monitoring patients for ADRs of the PRN medicine [28,86].
During training in medication reconciliation, which often includes PRN medications, sufficient
opportunities should be provided for nursing students to observe and practice PRN in an
interdisciplinary context, to become familiar with the multidisciplinary interactions involved in
medicines management and the healthcare setting’s medication policy [87–89].
Preparation of nursing students to safely perform PRN medicines management requires the
incorporation of innovative teaching methods [90]. For instance, digital technologies such as
offline/online computer-based methods help with improving more medication skills than traditional
education methods [91]. Watching video footage of medicines management and performing group
discussions as problem-based learning help make students aware of factors contributing to medication
errors [87]. Equally significant, simulations with high fidelity levels in the simulation laboratory and
the use of tools such as medDISPENSE as the automated dispensing system and the Personal Digital
Assistant (PDA) for digital recordings of the medication process are effective resources to reduce
medication errors by nursing students [21]. Overall, the integration of educational methods consisting
of simulation, group discussions and provision of feedback, case scenarios and problem-solving are a
key step forward in this aspect of nurse education [92,93]. This “nursing case-based learning” helps to
develop critical thinking abilities, based on situations in which decisions for safe medication practice
should be made [94,95].
Clinical instructors should use practical examples to link classroom and clinical settings, improve
medication calculation and medication administration skills and enhance the associated clinical
judgment through reflection and discussion [81]. In clinical practice situations, supervision and role
models during clinical rotations can help reduce medication errors by nursing students [96]. Role-play
simulation that involves engaging nursing students in administering medications, observing their
peers and/or causing interruptions and distractions improves their understanding of unfamiliar and
challenging situations that require cooperation, teamwork and collaboration between nursing staff to
reach the safe outcome of the medication process [97].
4.2.2. Independence and Interdependence in Decision Making
Nursing students need to be competent to make independent clinical decisions on PRN medicines
management, based on patient requests and their own clinical judgment, and including structured
monitoring for adverse side effects [41]. They should examine their own thinking process and
be prepared for unexpected and complex incidents in the medication process [98]. As a priority,
they should be educated to take responsibility for nurse-led care initiatives and assess the effects of
their own role on patients’ overall wellbeing and care outcomes [99].
Nursing students in clinical practice are not usually permitted to administer medication
independently, but decision-making skills for safe PRN medicines management in high-risk and
error-prone situations can be practiced in controlled situations and under the supervision of experienced
nurses [92]. Nursing staff can act as mentors to coordinate learning opportunities for students to
cope with real clinical situations that can cause anxiety, stress and distraction, helping to socialize
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them into their professional role and improving their capacity for evaluation and making clinical
decisions through performing a check on the suitability of the PRN medications in relation to a changed
pharmacokinetic status of the patient [78,90,100,101].
PRN medicines should be administered in conjunction with formal, structured checks for adverse
effects [41]. Double checking should be practiced to enhance the safety of the medication process and
prevent medication errors [102,103], along with other strategies such as reduced distractions, improved
lighting and minimized noise levels within the environment when making high-risk medication
decisions [104].
While the prescription and administration of PRN medications is the result of close nurse–patient
collaboration and decision-making, the participation of other healthcare professionals involved in the
medication process, such as physicians and pharmacists, is required for making the best decisions on
the selection of PRN medications. Therefore, nursing students should receive training on accessing
communication tools and contributing proactively to the decision-making process alongside other
healthcare providers [105–107]. They should be educated to value the skills and responsibilities of other
team members and respect their unique contributions in making decisions on medication safety [108].
The provision of interprofessional education, such as team-based learning, to students of medicine,
nursing and pharmacy, aimed at safe prescribing, dispensing and administering of medicines [108–111],
enhances competencies for safe PRN medicines management and reduces medication errors.
Information technology has transformed decision-making processes in medicines
management [112], particularly in the domains of documentation of nursing assessment, timing
and dosage of PRN medications, adherence to practice guidelines, patterns of PRN medication
prescription and administration, and monitoring of patient responses to medications [113]. Medicines
management systems such as barcoding, electronic medical records, as well as wheeled workstations
devised to reduce the potential for medication errors by giving nurses access to real-time information
before making crucial decisions for medicines management, should be incorporated into nursing
education goals [114].
4.2.3. Monitoring and Follow-Up
A frequently overlooked aspect of nursing education is improving students’ competencies in
assessing the patient’s care outcome during and after the medication process, and using the relevant
data in patient care [83]. In PRN medicines management, the responsibility of nurses to ensure the
safety of patients through appropriate follow up and monitoring during and after the medication
process is doubled, due to the voluntary nature of medication prescription and administration based
on the patient’s request [34].
Potential medication abuse by patients and the symptoms of addiction are further reasons for
careful monitoring and follow up by nurses [115]. Nursing students should practice monitoring
patients, with an emphasis on developing an understanding of how failures to assess and monitor
patients during PRN medication prescriptions and administration constitute medication errors that
need reporting [8,116].
In addition, the risk of unmonitored medication side effects and ADRs in healthcare settings
during PRN medicines management is high, and should be highlighted during nursing education [28].
Nursing students should be made familiar with the use of available monitoring tools in order to
assess and report ADRs as part of PRN prescription and administration. For instance, the medication
monitoring instrument, the Adverse Drug Reaction Profile (ADRe), emphasizes nurses’ professional
collaboration in multidisciplinary interventions and provides a structured method for monitoring,
detecting and ameliorating probable ADRs [28,40,41,117]. This profile can be completed by nurses
or carers alongside PRN medicines management, through the assessment of the patient’s health
conditions, highlighting possible and probable ADRs on a single screen or sheet of paper, which is
then passed to the pharmacist and physician. This informs a medication review process aiming at
changing medications or their doses [41,86,118].
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5. Conclusions
Nurses play a key role in PRN medicines management in terms of the preservation of patient
safety, the prevention of medication errors and the improvement of patient outcomes. Nursing
students are well-placed to learn about and practice how to safeguard PRN medicines management
by considering patient participation, theoretical and practical knowledge and skills, independent
decision-making, inter-professional collaboration, monitoring and follow-up. In addition to the
emphasis on the theoretical principles of PRN medicines management, attention should be paid to
its practical considerations, using appropriate educational strategies as outlined above. Given the
paucity of literature on this topic, however, there remains a pressing need for original research to
help us improve our understanding of the barriers to and the facilitators of effective PRN medicines
management by nurses in clinical practice.
Author Contributions: Conceptualization, M.V. and M.G.; methodology, M.V., S.J. and M.G.; writing—Original
draft preparation, review and editing, M.V., S.J., M.G., I.F. and F.V.-M. All authors have read and agreed to the
published version of the manuscript.
Funding: This research received no external funding.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Panagioti, M.; Khan, K.; Keers, R.N.; Abuzour, A.; Phipps, D.; Kontopantelis, E.; Bower, P.; Campbell, S.;
Haneef, R.; Avery, A.J.; et al. Prevalence, severity, and nature of preventable patient harm across medical
care settings: Systematic review and meta-analysis. BMJ 2019, 366, l4185. [CrossRef] [PubMed]
2. Rodziewicz, T.L.; Hipskind, J.E. Medical Error Prevention. In StatPearls; StatPearls Publishing LLC.:
Treasure Island, FL, USA, 2020.
3. Sunshine, J.E.; Meo, N.; Kassebaum, N.J.; Collison, M.L.; Mokdad, A.H.; Naghavi, M. Association of Adverse
Effects of Medical Treatment With Mortality in the United States: A Secondary Analysis of the Global Burden
of Diseases, Injuries, and Risk Factors Study. JAMA Netw. Open 2019, 2, e187041. [CrossRef] [PubMed]
4. Makary, M.A.; Daniel, M. Medical error—The third leading cause of death in the US. BMJ 2016, 353, i2139.
[CrossRef] [PubMed]
5. Aronson, J.K. Medication errors: Definitions and classification. Br. J. Clin. Pharmacol. 2009, 67, 599–604.
[CrossRef]
6. Hofer, T.P.; Kerr, E.A.; Hayward, R.A. What is an error? Eff. Clin. Pract. 2000, 3, 261–269.
7. Carver, N.; Gupta, V.; Hipskind, J.E. Medical Error. In StatPearls; StatPearls Publishing LLC.: Treasure Island,
FL, USA, 2020.
8. NCC MERP: National Co-ordinating Council for Medication Error Reporting and Prevention. NCC MERP:
About Medication Errors. What is a Medication Error? 2018. Available online: http://www.nccmerp.org/
about-medication-errors (accessed on 26 September 2020).
9. Bouvy, J.C.; De Bruin, M.L.; Koopmanschap, M.A. Epidemiology of adverse drug reactions in Europe:
A review of recent observational studies. Drug Saf. 2015, 38, 437–453. [CrossRef]
10. Hazell, L.; Shakir, S.A. Under-reporting of adverse drug reactions: A systematic review. Drug Saf. 2006, 29,
385–396. [CrossRef]
11. Wu, L.; Ingle, T.; Liu, Z.; Zhao-Wong, A.; Harris, S.; Thakkar, S.; Zhou, G.; Yang, J.; Xu, J.; Mehta, D.; et al.
Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA. BMC Bioinform.
2019, 20, 97. [CrossRef]
12. World Health Organization (WHO). Reporting and Learning Systems for Medication Errors: The Role of
Pharmacovigilance Centres. 2014. Available online: https://www.who.int/medicines/areas/quality_safety/
safety_efficacy/emp_mes/en/ (accessed on 17 September 2020).
13. Khalil, H.; Bell, B.; Chambers, H.; Sheikh, A.; Avery, A.J. Professional, structural and organisational
interventions in primary care for reducing medication errors. Cochrane Database Syst. Rev. 2017, 10, Cd003942.
[CrossRef]
Pharmacy 2020, 8, 201 10 of 15
14. Kavanagh, C. Medication governance: Preventing errors and promoting patient safety. Br. J. Nurs. 2017, 26,
159–165. [CrossRef]
15. Palese, A.; Gonella, S.; Grassetti, L.; Mansutti, I.; Brugnolli, A.; Saiani, L.; Terzoni, S.; Zannini, L.; Destrebecq, A.;
Dimonte, V. Multi-level analysis of national nursing students’ disclosure of patient safety concerns. Med. Educ.
2018, 52, 1156–1166. [CrossRef] [PubMed]
16. Vaismoradi, M.; Salsali, M.; Marck, P. Patient safety: Nursing students’ perspectives and the role of nursing
education to provide safe care. Int. Nurs. Rev. 2011, 58, 434–442. [CrossRef]
17. GuKG, N. Gesundheits-und Krankenpflegegesetz 1997, BGBI.INr.108/1997i.d.F.BGBl.INr.8/2016. 1997.
Available online: https://www.ris.bka.gv.at/Dokumente/BgblAuth/BGBLA_2016_I_75/BGBLA_2016_I_75.pdf
(accessed on 17 September 2020).
18. Health Information and Quality Authority (HIQA). Medicines Management Guidance. 2015. Available
online: https://www.hiqa.ie/sites/default/files/2017-01/Medicines-Management-Guidance.pdf (accessed on
17 September 2020).
19. Covell, C.L.; Ritchie, J.A. Nurses’ responses to medication errors: Suggestions for the development of
organizational strategies to improve reporting. J. Nurs Care Qual. 2009, 24, 287–297. [CrossRef] [PubMed]
20. Rohde, E.; Domm, E. Nurses’ clinical reasoning practices that support safe medication administration:
An integrative review of the literature. J. Clin. Nurs. 2018, 27, e402–e411. [CrossRef] [PubMed]
21. Asensi-Vicente, J.; Jiménez-Ruiz, I.; Vizcaya-Moreno, M.F. Medication Errors Involving Nursing Students:
A Systematic Review. Nurse Educ. 2018, 43, E1–E5. [CrossRef]
22. Cronenwett, L.R.; Bootman, J.L.; Wolcott, J.; Aspden, P.; Institute of Medicine Board on Health Care Services;
Committee on Identifying and Preventing Medication Errors (Eds.) Preventing Medication Errors (Quality
Chasm); National Academies Press: Washington, DC, USA, 2007. Available online: https://www.nap.edu/
initiative/committee-on-identifying-and-preventing-medication-errors (accessed on 17 September 2020).
23. World Health Organization (WHO). Patient Safety: Data and Statistics. 2020. Available online:
https://www.euro.who.int/en/health-topics/Health-systems/patient-safety/data-and-statistics (accessed on
17 September 2020).
24. Escrivá Gracia, J.; Brage Serrano, R.; Fernández Garrido, J. Medication errors and drug knowledge gaps
among critical-care nurses: A mixed multi-method study. BMC Health Serv. Res. 2019, 19, 640. [CrossRef]
25. Moyen, E.; Camiré, E.; Stelfox, H.T. Clinical review: Medication errors in critical care. Crit. Care 2008, 12, 208.
[CrossRef]
26. Slight, S.P.; Tolley, C.L.; Bates, D.W.; Fraser, R.; Bigirumurame, T.; Kasim, A.; Balaskonis, K.; Narrie, S.;
Heed, A.; Orav, E.J.; et al. Medication errors and adverse drug events in a UK hospital during the optimisation
of electronic prescriptions: A prospective observational study. Lancet Digit. Health 2019, 1, e403–e412.
[CrossRef]
27. Berland, A.; Bentsen, S.B. Medication errors in home care: A qualitative focus group study. J Clin. Nurs.
2017, 26, 3734–3741. [CrossRef]
28. Vaismoradi, M.; Vizcaya Moreno, F.; Sletvold, H.; Jordan, S. PRN Medicines Management for Psychotropic
Medicines in Long-Term Care Settings: A Systematic Review. Pharmacy 2019, 7, 157. [CrossRef]
29. Ferrah, N.; Lovell, J.J.; Ibrahim, J.E. Systematic Review of the Prevalence of Medication Errors Resulting in
Hospitalization and Death of Nursing Home Residents. J. Am. Geriatr. Soc. 2017, 65, 433–442. [CrossRef]
[PubMed]
30. Pegram, A.; Bloomfield, J. Medicines management. Nurs. Stand. 2015, 29, 36–43. [CrossRef]
31. Shahbazi, S.; Valizadeh, S.; Borimnejad, L.; Rahmani, A.; Vaismoradi, M. Living With Moral Distress:
The Perspectives and Experiences of Iranian Nurse Preceptors. Res. Theory Nurs. Pract. 2018, 32, 355–369.
[CrossRef] [PubMed]
32. World Health Organization (WHO). WHO Launches Global Effort to Halve Medication-Related Errors in
5 Years. 2017. Available online: http://www.who.int/mediacentre/news/releases/2017/medication-related-
errors/en/ (accessed on 17 September 2020).
33. Martin, K.; Arora, V.; Fischler, I.; Tremblay, R. Descriptive analysis of pro re nata medication use at a Canadian
psychiatric hospital. Int. J. Ment. Health Nurs. 2017, 26, 402–408. [CrossRef]
34. Vaismoradi, M.; Amaniyan, S.; Jordan, S. Patient Safety and Pro Re Nata Prescription and Administration:
A Systematic Review. Pharmacy 2018, 6, 95. [CrossRef]
35. Adelaide, D.; Rawther, F. Audit: Prescribing PRN medication. Psychiatr. Danub. 2017, 29, 568–570.
Pharmacy 2020, 8, 201 11 of 15
36. Griffiths, A.W.; Surr, C.A.; Alldred, D.P.; Baker, J.; Higham, R.; Spilsbury, K.; Thompson, C.A. Pro re nata
prescribing and administration for neuropsychiatric symptoms and pain in long-term care residents with
dementia and memory problems: A cross-sectional study. Int. J. Clin. Pharm. 2019, 41, 1314–1322. [CrossRef]
37. Picton, L.; Ilomäki, J.; Keen, C.S.; Lalic, S.; Adams, B.; Clinnick, L.M.; Kirkpatrick, C.M.; Ryan-Atwood, T.;
Turner, J.P.; Bell, J.S. Rates of PRN Medication Administration in Australian Residential Aged Care. J. Am.
Med. Dir. Assoc. 2020. [CrossRef]
38. Stasinopoulos, J.; Bell, J.S.; Ryan-Atwood, T.E.; Tan, E.C.K.; Ilomäki, J.; Cooper, T.; Robson, L.; Sluggett, J.K.
Frequency of and factors related to pro re nata (PRN) medication use in aged care services. Res. Soc.
Adm. Pharm. 2018, 14, 964–967. [CrossRef]
39. Martin, K.; Ham, E.; Hilton, N.Z. Staff and patient accounts of PRN medication administration and
non-pharmacological interventions for anxiety. Int. J. Ment. Health Nurs. 2018, 27, 1834–1841. [CrossRef]
40. Jordan, S.; Banner, T.; Gabe-Walters, M.; Mikhail, J.M.; Panes, G.; Round, J.; Snelgrove, S.; Storey, M.;
Hughes, D. Nurse-led medicines’ monitoring in care homes, implementing the Adverse Drug Reaction
(ADRe) Profile improvement initiative for mental health medicines: An observational and interview study.
PLoS ONE 2019, 14, e0220885. [CrossRef] [PubMed]
41. Jordan, S.; Logan, P.A.; Panes, G.; Vaismoradi, M.; Hughes, D. Adverse Drug Reactions, Power, Harm
Reduction, Regulation and the ADRe Profiles. Pharmacy 2018, 6, 102. [CrossRef] [PubMed]
42. Baumann, S.L.; Greif, N. The use of PRNs medications with hospitalized older adults. Geriatr. Nurs. 2017, 38,
596–598. [CrossRef]
43. Tong, Y.; Chen, J.; Chai, L.; Yang, L.; Zhang, C.; Liu, M. Current State of Pain Resource Nurse (PRN) Programs
and Experiences of PRNs in China. Pain Manag. Nurs. 2019, 20, 174–182. [CrossRef] [PubMed]
44. Hipp, K.; Kuosmanen, L.; Repo-Tiihonen, E.; Leinonen, M.; Louheranta, O.; Kangasniemi, M. Patient
participation in pro re nata medication in psychiatric inpatient settings: An integrative review. Int. J. Ment.
Health Nurs. 2018, 27, 536–554. [CrossRef]
45. Usher, K.; Holmes, C.; Lindsay, D.; Luck, L. PRN psychotropic medications: The need for nursing research.
Contemp. Nurse 2003, 14, 248–257. [CrossRef]
46. Abdallah, M.S.; Sheikh, M.A.; Alaqqad, A.; Alharthy, A.; Aldossari, M.; Alodat, M.; Kurdi, M.; Salem, S.;
Mady, A.F. PRN Medications Ordering Practice at a Large Intensive Care Unit in Saudi Arabia. J. Intensiv.
Crit. Care 2016, 2, 1–5. [CrossRef]
47. Asogwa, K.; Okudo, J.; Idowu, J. The use and effectiveness of pro re nata psychotropic medications in
children and adolescents: A systematic review. Indian J. Psychiatry 2017, 59, 264–274. [CrossRef]
48. Jimu, M.; Doyle, L. The Administration of Pro re nata Medication by Mental Health Nurses: A Thematic
Analysis. Issues Ment. Health Nurs. 2019, 40, 511–517. [CrossRef]
49. Dörks, M.; Allers, K.; Hoffmann, F. Pro Re Nata Drug Use in Nursing Home Residents: A Systematic Review.
J. Am. Med. Dir. Assoc. 2019, 20, 287–293. [CrossRef]
50. Salazar, A.; Karmiy, S.J.; Forsythe, K.J.; Amato, M.G.; Wright, A.; Lai, K.H.; Lambert, B.L.; Liebovitz, D.M.;
Eguale, T.; Volk, L.A.; et al. How often do prescribers include indications in drug orders? Analysis of
4 million outpatient prescriptions. Am. J. Health Pharm. 2019, 76, 970–979. [CrossRef] [PubMed]
51. Dörks, M.; Schmiemann, G.; Hoffmann, F. Pro re nata (as needed) medication in nursing homes: The longer
you stay, the more you get? Eur. J. Clin. Pharmacol. 2016, 72, 995–1001. [CrossRef] [PubMed]
52. Martin, K.; Ham, E.; Hilton, N.Z. Documentation of psychotropic pro re nata medication administration:
An evaluation of electronic health records compared with paper charts and verbal reports. J. Clin. Nurs.
2018, 27, 3171–3178. [CrossRef]
53. Paton, C.; Barnes, T.R.; Cavanagh, M.R.; Taylor, D.; Lelliott, P. High-dose and combination antipsychotic
prescribing in acute adult wards in the UK: The challenges posed by p.r.n. prescribing. Br. J. Psychiatry
2008, 192, 435–439. [CrossRef]
54. Hammer, A.; Wagner, A.; Rieger, M.A.; Manser, T. Assessing the quality of medication documentation:
Development and feasibility of the MediDocQ instrument for retrospective chart review in the hospital
setting. BMJ Open 2019, 9, e034609. [CrossRef]
55. Tyrrell-Bunge, E.; de Carvalho, A.F.; Scott, C.; Tomlin, S.; Treasure, J.; Himmerich, H. A three level-intervention
to reduce PRN medication on a specialist eating disorders ward for adult female patients with anorexia
nervosa. Psychiatr. Danub. 2018, 30, 107–108.
Pharmacy 2020, 8, 201 12 of 15
56. Flinkman, M.; Leino-Kilpi, H.; Numminen, O.; Jeon, Y.; Kuokkanen, L.; Meretoja, R. Nurse Competence
Scale: A systematic and psychometric review. J. Adv. Nurs. 2017, 73, 1035–1050. [CrossRef]
57. Goedhart, N.S.; van Oostveen, C.J.; Vermeulen, H. The effect of structural empowerment of nurses on quality
outcomes in hospitals: A scoping review. J. Nurs. Manag. 2017, 25, 194–206. [CrossRef]
58. Nilsen, M.K.; Sletvold, H.; Olsen, R.M. ‘To give or not to give medication, that is the question.’
Healthcare personnel’s perceptions of factors affecting pro re nata medication in sheltered housing for older
adults—A focus-group interview study. BMC Health Serv. Res. 2020, 20, 622. [CrossRef]
59. Náfrádi, L.; Nakamoto, K.; Schulz, P.J. Is patient empowerment the key to promote adherence? A systematic
review of the relationship between self-efficacy, health locus of control and medication adherence. PLoS ONE
2017, 12, e0186458. [CrossRef] [PubMed]
60. Holmqvist, M.; Thor, J.; Ros, A.; Johansson, L. Older persons’ experiences regarding evaluation of their
medication treatment—An interview study in Sweden. Health Expect. 2019, 22, 1294–1303. [CrossRef]
61. Look, K.A.; Stone, J.A. Medication management activities performed by informal caregivers of older adults.
Res. Soc. Adm. Pharm. 2018, 14, 418–426. [CrossRef] [PubMed]
62. Manias, E.; Bucknall, T.; Hughes, C.; Jorm, C.; Woodward-Kron, R. Family involvement in managing
medications of older patients across transitions of care: A systematic review. BMC Geriatr. 2019, 19, 95.
[CrossRef] [PubMed]
63. Pohontsch, N.J.; Löffler, A.; Luck, T.; Heser, K.; Parker, D.; Haenisch, B.; Riedel-Heller, S.G.; Jessen, F.;
Scherer, M. Informal caregivers’ perspectives on health of and (potentially inappropriate) medication
for (relatively) independent oldest-old people-a qualitative interview study. BMC Geriatr. 2018, 18, 169.
[CrossRef]
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